EMEA-002267-PIP03-19 - paediatric investigation plan

Gefapixant (citrate salt)
PIPHuman

Key facts

Active Substance
Gefapixant (citrate salt)
Therapeutic area
Endocrinology-Gynaecology-Fertility-Metabolism
Decision number
P/0100/2020
PIP number
EMEA-002267-PIP03-19
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of endometriosis
Route(s) of administration
Oral use
Contact for public enquiries

Merck, Sharp & Dohme (Europe) Inc.

Tel. +33 180464738
E-mail: pip.information@merck.com

Decision type
W: decision granting a waiver in all age groups for all conditions or indications
Decision date

Decision

Share this page